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• Research investigating the developmental origins of health and disease (DOHAD) has 
never before had the technology to investigate physiology in such a data-rich capacity 
at such a micro-level.  
• A symposium presented at the inaugural meeting of the DOHAD Society of Australia 
and New Zealand outlined the advantages and challenges of using “-omics” 
technologies in DOHAD research. 
• DOHAD studies utilising “-omics” approaches to generate large, rich datasets were 
highlighted. 
• Implications for policy and practise are discussed, and recommendations made to 
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Studies exploring the developmental origins of health and disease (DOHAD) investigate how 
early life exposures increase susceptibility to later adverse health outcomes, both from a 
medical and public health perspective. This altered health risk appears to occur through 
reprogramming of physiological systems away from their normal developmental trajectories, 
highlighting the plasticity of organ systems in the perinatal periods (1). Recent research in 
this field has focused on the potential for these physiological changes to exert trans-
generational effects, without the requirement for further exposures in subsequent 
generations (2). This appears to occur through genetic and environmental interactions, 
resulting in phenotypic changes that persist across generations.  
 
The emergence of “-omics” biotechnologies has revolutionised physiological research in the 
DOHAD field. From the genome, to the epigenome, microbiome and metabolome – research 
investigating pathways leading to disease has never before had the technology to investigate 
physiology in such a high throughput, data-rich capacity. This commentary summarises this 
emerging research capability and its application in DOHAD studies to explain how 
environmental and social factors impact our physiology and become inherited, leaving a 
legacy of disease susceptibility for future generations. The current challenges of employing 
such technologies will be discussed, suggestions made to facilitate successful application of 
these platforms in future studies and to inform policy and practise. 
 
The Epigenome 
The epigenome refers to the changes made to the genome which result in altered 
transcriptional activity in the absence of DNA sequence alterations. This is a highly dynamic 
process, occurring in response to a number of external factors, with the changes stably 
maintained and enduring over multiple generations. Epigenetic mechanisms regulating gene 
expression include DNA methylation, histone modifications and the actions of small non-
coding RNAs, each contributing to tissue specific gene expression and altered cellular 
phenotype. The introduction of high throughput sequencing and microarray techniques has 
facilitated the study of these epigenetic mechanisms in the DOHAD field.  
 
The interaction between epigenetic inheritance and environmental exposures (for example 
diet, stress, drug exposures) has been recognised as an important determinant of 
phenotypic outcomes for their offspring (1). Exposures of the mother (F0 generation) can 
result in epigenetic modifications in both the developing fetus (F1) and the germline (F2) (3). 
Such transmission is not restricted to maternal exposures, with recent evidence that 
epigenetic modifications are also inheritable down the paternal line (4). Specifically, a 
murine model of paternal obesity has demonstrated altered methylation and microRNA 
profiles (4), highlighting the role of the father’s contribution to inheritable disease 
susceptibility. While evidence supporting trans-generational epigenetic inheritance has 
primarily been derived from rodent studies, large multi-generational epidemiological studies 
support this transmission pattern. Data from the Överkalix Swedish tri-generation 
population study has demonstrated that the mortality risk ratio of grandchildren was 
associated with the food supply available to their same sex paternal grandparent (5). 
Whether an epigenetic mode of inheritance can contribute to such human outcomes is as 
yet unknown, but is expected given the strong parallels observed between the animal and 
human trans-generational studies.  Further, changes in DNA methylation of genes well 
known to be involved in regulating fetal growth and development, such as the NR3C1 gene 
which encodes the glucocorticoid receptor, have already been demonstrated in humans 
following early life adverse exposures. For example, maternal depression in the third 
trimester of pregnancy is associated with increased methylation of the NR3C1 gene in cord 
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blood mononuclear cells, in conjunction with altered stress responses in the infants at three 
months of age (6). Increased methylation of this same gene is found in brain tissue of 
adolescents with a history of child abuse who later committed suicide (7), and in 
lymphocytes of 11-21 year olds following childhood maltreatment, and is associated with 
poor psychological health (8). Together, these studies provide evidence of the role of early 
epigenetic modifications in increasing vulnerability to poor long term health in humans.  
 
The Microbiome 
The human microbiome is the collection of micro-organisms that inhabit the human body, 
including commensal and symbiotic microbes. The study of the microbiome and its role in 
disease onset has been made possible by the introduction of large-scale sequencing 
techniques and gene expression arrays. These techniques have increased our ability to 
understand the contribution of the maternal microbiome to disease in subsequent 
generations. For example, altered bacterial colonisation of the alimentary tract of piglets 
following antibiotic and stress exposure in early life has been associated with immune 
development perturbations (9). This may have particular implications for preterm children, 
where both of these exposures are common in early life. Already, preliminary studies of the 
microbiome in preterm twins have demonstrated that an altered pattern of microbial gut 
colonisation precedes the development of necrotising enterocolitis (10). The potential for 
other common prenatal exposures to influence the maternal and neonatal microbiomes, 
including obesity (11) and smoking (12), as well as different modes of delivery (13), have also 
started to receive research attention in the DOHAD field. Further, the potential for an 




The metabolome is the complete set of metabolites, or low molecular mass compounds, 
found in biological samples that regulate cell and tissue growth, development, survival, 
maintenance and responses to the environment. As the downstream product of gene 
expression and transcriptional activity, the potential for metabolomic profiling to provide a 
phenotypic signature of pathophysiology has been recognised (15). Methods used to assess 
the metabolome rely on high resolution analytics including mass spectrometry (coupled with 
compound separation processes), nuclear magnetic resonance spectrometry and Fourier 
transform infrared spectroscopy. Unlike both the epigenome and the microbiome, the 
metabolome can be highly dynamic, able to change in short time frames, ranging from 
seconds to minutes. The choice of sampling material is therefore an important consideration 
(e.g. blood samples reflect highly dynamic responses while hair samples reflect prolonged 
exposure and are therefore a more stable phenotype (16)), and will be specific to the 
research question and critical to the interpretation of results. The large volume of data 
generated by such techniques can provide insight into interactions between metabolites, 
genes, transcripts and proteins (17). As such, these data can be highly informative of 
mechanisms leading to disease and understanding the impact of environmental exposures 
on system physiology. The potential for metabolomics platforms to be used to identify 
biomarkers predicting pregnancy outcome is already becoming apparent. These include 
observations of differences in the neonatal blood metabolome across gestational age which 
are dependent on postnatal age at sampling (18), specific pathology and illness severity (19), 
studies linking the maternal hair metabolome with fetal growth restriction (16) and the 
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Challenges to “–omics” approaches in DOHAD research  
Utilisation of these emerging platforms in DOHAD research shows clear promise in 
expanding our current knowledge of the mechanisms driving the intergenerational 
transmission of disease and heightening disease susceptibility in individuals following 
specific exposures in early development. While the provision of such large volumes of 
biological data using these “–omics” approaches provides enormous opportunity, a number 
of challenges remain in their application and interpretation. The first clear challenge relates 
to identifying the appropriate time for tissue sampling, given the current limited use of these 
approaches in this field. Furthermore, "healthy" ranges are yet to be established. This 
limitation exists with any advance in technology and will be overcome through public 
sharing of “-omics” data. In order to establish these ranges, sampling from multiple time 
points and multiple tissues will be necessary. This information will benefit the design of 
future studies where sampling can then occur at single time point during tissue-specific 
sensitive periods to yield the most meaningful (reliable, valid and interpretable) data.  The 
development of “normative” ranges will also help address many of the other current 
unknowns in this area. These include understanding what sample size is needed to identify 
meaningful effects; understanding and predicting the stability of an “–omics” profile; 
identifying how a “second-hit” or multiple exposures impact; understanding whether the 
duration or timing of each exposure important in determining outcome; and understanding 
whether a genetic susceptibility is needed for the intergenerational transmission of poor 
outcomes or whether this is a highly conserved process. These questions are of fundamental 
importance in the design of DOHAD studies, to ensure they are conducted in a cost- and 
time-effective manner.  
 
Once we have identified biomarkers or signatures predictive of poor maternal, fetal or 
neonatal outcomes, the next critical step is to use this information to identify how to 
normalise these effects. This will necessitate an understanding of how postnatal factors 
influence (normalise or exacerbate) the “–omics” profile induced by the early life 
environment. Longitudinal studies of twins have provided some preliminary evidence of 
environmental influences, exploring the stability of the epigenome across the first 18 
months of life and the degree of epigenetic discordance between siblings with a shared 
genetic and environmental background (21). Continued longitudinal assessments of these 
children will increase our understanding of the role of the environment on the epigenome 
across the life course. Further, the impact of additional exposures in pregnancies of these 
subsequent generations has yet to be identified. As few studies have assessed the potential 
for “–omics” profiles to be modified beyond the F2 generation (2), there is a clear lack of 
data informing this latter challenge.  
 
Recommendations for future studies 
The emerging evidence shows clear promise in expanding our understanding of the 
developmental origins of health and disease. Collaborative studies are highly recommended, 
integrating data derived from multiple “–omics” platforms, collected from samples across 
early development and linked to clinical health outcomes. Analysis of samples derived from 
current and planned randomised controlled trials will allow the impact of standard care and 
interventions to be assessed concurrently. Together these studies will facilitate our 
understanding of disease susceptibility, onset and progression to a degree that has not 
previously been possible.  This is an exciting time for biological research in the DOHAD field – 
offering the potential to understand complex biological interactions between systems that 
contribute to health outcomes across generations. 
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Implications for Policy and Practice 
The basic tenet of DOHAD research is that perinatal health behaviours of both the mother 
and father, as well as those of the child in early life, can significantly impact on the future 
health of the child and that of subsequent generations. This implies that effective 
interventions applied at critical periods of development can substantially reduce future 
disease burden. The potential for this research to be translated into tangible health benefits 
for child health and future generations is therefore enormous, aligning perfectly with the 
growing demands of national health regulatory bodies to focus efforts on preventative 
health care. The integration of –omics technologies into DOHAD research will increase our 
understanding of biological mechanisms underlying the transgenerational transmission of 
disease, and how interventions normalise these effects.  The outcomes of this research can 
then be used by health advocates to inform policy and practice, by clinicians and health 
workers to promote and support healthy perinatal behaviours, and be communicated to the 
wider community to optimise future child health. 
 
While information on DOHaD and early life healthy behaviours is becoming more readily 
available, it is unclear whether this is being effectively communicated to the health care 
providers that need it most, i.e. those in direct contact with women who are pregnant or 
planning a pregnancy.  For example, surveys of general practitioners reveal a limited 
knowledge of nutritional requirements for pregnancy, with many feeling uncomfortable 
providing this information due to lack of confidence (22). Knowledge gaps such as this must 
be urgently addressed to optimise the health of future populations. Similarly, while the 
internet is teeming with websites offering advice for pregnant and breastfeeding women, 
these often contain inaccurate or misleading advice and conflicting information. Evidenced-
based, on-line resources to which women can be directed for accurate health information 
are needed.  Overcoming these, along with other challenges in translating the concepts of 
DOHaD effectively into policy and practice, forms the core agenda of the newly formed 
Australia and New Zealand DOHaD Society.  
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